AuraVax Therapeutics Inc. receives grant for viral challenge study of new broad acting host-directed therapeutic

Company receives grant from the Gates Foundation to evaluate the NanoSTING platform HOUSTON, Sept. 15, 2025 /PRNewswire/ -- AuraVax Therapeutics, Inc. has received funding from the Gates Foundation to evaluate the efficacy of NanoSTING-001 in a swine disease model at Kansas State...